SMS Pharmaceuticals Ltd.
| BSE: 532815 | Sector: Health care |
| NSE: SMSPHARMA | ISIN Code: INE812G01025 |
| BSE 00:00 | 23 Mar | 65.14 |
0.25 (0.39%) |
OPEN
66.65 |
HIGH
66.65 |
LOW
63.95 |
| NSE 00:00 | 23 Mar | 64.90 |
0.05 (0.08%) |
OPEN
65.45 |
HIGH
66.55 |
LOW
64.45 |
| OPEN | 66.65 |
| PREVIOUS CLOSE | 64.89 |
| VOLUME | 205215 |
| 52-Week high | 114.90 |
| 52-Week low | 60.10 |
| P/E | 108.57 |
| Mkt Cap.(Rs cr) | 552 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
SMS Pharmaceuticals Ltd. (SMSPHARMA) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Cipla | 869.50 | 6.10 | 0.71 | 2957.93 |
| Divi's Lab. | 2801.05 | 11.05 | 0.40 | 2948.54 |
| Glenmark Pharma. | 436.70 | 0.35 | 0.08 | 1997.79 |
| Glaxosmi. Pharma | 1294.15 | 12.45 | 0.97 | 1690.53 |
| Dr Reddy's Labs | 4447.95 | -28.05 | -0.63 | 1623.20 |
| Alkem Lab | 3148.90 | -65.30 | -2.03 | 1541.25 |
| Aurobindo Pharma | 486.15 | 7.05 | 1.47 | 1454.71 |
| Gland Pharma | 1294.65 | 49.65 | 3.99 | 1212.16 |
| Torrent Pharma. | 1531.20 | 12.25 | 0.81 | 991.45 |
| Sanofi India | 5680.70 | -17.85 | -0.31 | 944.40 |
| Ipca Labs. | 784.85 | 2.80 | 0.36 | 870.94 |
| Zydus Lifesci. | 482.35 | 3.80 | 0.79 | 857.90 |
| Abbott India | 21550.15 | 77.30 | 0.36 | 798.70 |
| Laurus Labs | 303.05 | -2.15 | -0.70 | 750.09 |
| Ajanta Pharma | 1230.80 | 12.25 | 1.01 | 719.86 |
| Apollo Hospitals | 4271.10 | -8.25 | -0.19 | 665.20 |
| Pfizer | 3515.75 | -15.20 | -0.43 | 612.56 |
| Suven Pharma | 471.40 | -0.45 | -0.10 | 558.10 |
| Alembic Pharma | 488.95 | -7.10 | -1.43 | 543.55 |
| Glenmark Life | 413.30 | -1.80 | -0.43 | 418.72 |
Quick Links for SMS Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
